GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (STU:698) » Definitions » Net Interest Income (for Banks)

Achilles Therapeutics (STU:698) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Achilles Therapeutics (STU:698) Business Description

Traded in Other Exchanges
Address
245 Hammersmith Road, London, GBR, W6 8PW
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.